source
- Simlukafusp Alfa plus atezolizumab shows safety but no benefit over standard care in metastatic kidney cancerA clinical study evaluated the novel immunocytokine simlukafusp alfa combined with atezolizumab, with or without bevacizumab, in patients with unresectable metastatic renal cell carcinoma. The com…
- Study links specific dietary fats to pancreatic cancer risk, highlighting oleic acid as promoter and omega-3s as protectiveResearchers at Yale Cancer Center examined how different types of dietary fat affect pancreatic cancer development in a mouse model. Rather than focusing on total fat intake, the study compared twe…